Drugs / fecal microbiota capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04521205 | Dec 2020 → Dec 2023 | ulcerative colitis | Zhongshan Hospital Xiamen University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04521205 ↗ |
| Modality | Other / unclassified | “standardized fecal microbiota transplantation” NCT04521205 ↗ |
| Route | Oral | “The FMT was given by capsule.” NCT04521205 ↗ |